CAMPBELL, Calif., September 28, 2021 / PRNewswire / – Shifamed LLC, a Highly Specialty Medical Innovation Center, Publicly Announces Acquisition of NuVera Medical from Biosense Webster, the Global Leader in Cardiac Arrhythmia Treatment and Part of the Johnson & Johnson Medical Device Companies*. This transaction, concluded in december 2020, generated an impressive return for investors in Shifamed shares.
“We are delighted that the ICE NuVision Catheter is now part of Biosense Webster’s electrophysiology product portfolio and are delighted to see them advance this innovation,” commented Amr Salahieh, Founder and CEO of Shifamed.
The NuVision ICE Catheter is advanced ultrasound technology that allows physicians to view complex intracardiac structures from a whole new perspective. With a 90 x 90 field of view and high-resolution, real-time image rendering, this new technology is poised to transform electrophysiological ablation and structural heart procedures.
About Shifamed, LLC.
Founded by serial entrepreneur Amr Salahieh, Shifamed LLC is a highly specialized medical innovation hub focused on developing solutions that accelerate time to market, reduce risk, increase impact, and pave the way for a world where patients can lead longer, healthier lives. To learn more about Shifamed, please visit www.shifamed.com.
CONTACT WITH THE MEDIA:
SPRIG Consulting LLC
+1 (408) 805-0520
*Johnson & Johnson Medical Devices companies include the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment. Biosense Webster, Johnson & Johnson, and NuVision are registered trademarks of Johnson & Johnson.
SOURCE Shifamed LLC